Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial

Authors

Michael Untch (ORCID: https://orcid.org/0000-0002-1233-1267)
Andri Papakonstantinou (ORCID: https://orcid.org/0000-0002-4232-4658)
Michael Gnant (ORCID: https://orcid.org/0000-0003-1002-2118)
Nikos Tsiknakis (ORCID: https://orcid.org/0000-0002-7581-467X)
Alexios Matikas (ORCID: https://orcid.org/0000-0002-4122-9624)
Richard Greil (ORCID: https://orcid.org/0000-0002-4462-3694)
Theodoros Foukakis (ORCID: https://orcid.org/0000-0001-8952-9987)
Mats Hellström (ORCID: https://orcid.org/0000-0001-7897-4006)
Jonas Bergh (ORCID: https://orcid.org/0000-0001-5526-1847)
Volker Möbus (ORCID: https://orcid.org/0000-0002-4892-008X)
Hemming Johansson (ORCID: https://orcid.org/0000-0002-7156-1468)
Sibylle Loibl (ORCID: https://orcid.org/0000-0001-6488-4958)
Günther Steger

Institutions

Goethe University Frankfurt (DE)
Paracelsus Medical University (AT)
Karolinska Institutet (SE)
Comprehensive Cancer Center Vienna (AT)
German Breast group (DE)
University Hospital Frankfurt (DE)
Helios Hospital Berlin-Buch (DE)
Frankfurt University of Applied Sciences (DE)
Medical University of Vienna (AT)

Publication Details

Journal: The Lancet Regional Health - Europe
Published: 2024-12-03
DOI: https://doi.org/10.1016/j.lanepe.2024.101162
Citations: 6
Primary Topic: Breast Cancer Treatment Studies
Type: article
Field-Weighted Citation Impact: 1.71

Funders

Amgen
Sanofi
Cancerfonden
Svenska Sällskapet för Medicinsk Forskning

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial

Michael Untch, Andri Papakonstantinou, Michael Gnant, Nikos Tsiknakis et al.

Dec 3, 2024

6 citations

The Lancet Regional Health - Europe

Breast Cancer Treatment Studies

1.71

article

Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trial

Michael Untch, Andri Papakonstantinou, Michael Gnant, Nikos Tsiknakis, Alexios Matikas, Richard Greil, Theodoros Foukakis, Mats Hellström, Jonas Bergh, Volker Möbus, Hemming Johansson, Sibylle Loibl, Günther Steger

December 3, 2024article en

6 citations

Abstract

No abstract available for this paper.

The Lancet Regional Health - EuropeVol. 49

Goethe University Frankfurt (DE), Paracelsus Medical University (AT), Karolinska Institutet (SE), Comprehensive Cancer Center Vienna (AT), German Breast group (DE), University Hospital Frankfurt (DE), Helios Hospital Berlin-Buch (DE), Frankfurt University of Applied Sciences (DE), Medical University of Vienna (AT)

Amgen, Sanofi, Cancerfonden, Svenska Sällskapet för Medicinsk Forskning

Good health and well-being

Openalex Percentile: Top 14%

Breast Cancer Treatment Studies

1.71

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.